We are live on ! Find out more
PCM

Polaris Capital Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+17.01%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$2.87B
AUM Growth
+$323M
Cap. Flow
-$35.8M
Cap. Flow %
-1.25%
Top 10 Hldgs %
44.38%
Holding
103
New
3
Increased
36
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$49.6M
2
NTRS icon
Northern Trust
NTRS
+$47.4M
3
MKSI icon
MKS Inc
MKSI
+$45.8M
4
IPG
Interpublic Group of Companies
IPG
+$25.7M
5
AVT icon
Avnet
AVT
+$15M

Top Sells

Rank Stock Value
1
CNK icon
Cinemark Holdings
CNK
+$46.7M
2
MPC icon
Marathon Petroleum
MPC
+$40.4M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$31.8M
4
FDX icon
FedEx
FDX
+$31M
5
BPOP icon
Popular Inc
BPOP
+$29.4M

Sector Composition

Rank Sector Weight
1 Financials 24.83%
2 Healthcare 23.4%
3 Consumer Discretionary 13.91%
4 Materials 10.02%
5 Technology 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIN icon
1
Linde
LIN
$237B
$210M 7.32%
644,393
-21,400
-3% -$6.71M
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$16.1B
$200M 6.95%
1,253,360
-217,100
-15% -$31.8M
BPOP icon
3
Popular Inc
BPOP
$11B
$188M 6.55%
2,835,878
-423,300
-13% -$29.4M
AMCR icon
4
Amcor
AMCR
$21.2B
$184M 6.39%
3,084,514
-116,640
-4% -$6.8M
NOMD icon
5
Nomad Foods
NOMD
$1.77B
$125M 4.34%
7,226,400
-70,900
-1% -$1.12M
UTHR icon
6
United Therapeutics
UTHR
$26.2B
$89.4M 3.11%
321,400
-20,500
-6% -$5.18M
CROX icon
7
Crocs
CROX
$6.61B
$79.7M 2.78%
735,406
+2,900
+0.4% +$256K
ABBV icon
8
AbbVie
ABBV
$466B
$68M 2.37%
420,558
-1,000
-0.2% -$153K
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$67.9M 2.36%
+596,900
New +$49.6M
ELV icon
10
Elevance Health
ELV
$81.7B
$63.7M 2.22%
124,231
-4,420
-3% -$2.24M
JPM icon
11
JPMorgan Chase
JPM
$916B
$63.3M 2.21%
472,351
+5,900
+1% +$748K
CVS icon
12
CVS Health
CVS
$135B
$61.8M 2.15%
662,900
+10,900
+2% +$1.05M
CB icon
13
Chubb
CB
$140B
$60.6M 2.11%
274,849
-9,800
-3% -$2.04M
WMB icon
14
Williams Companies
WMB
$85.5B
$59.4M 2.07%
1,805,400
+8,600
+0.5% +$280K
UNH icon
15
UnitedHealth
UNH
$382B
$58.6M 2.04%
110,456
+1,800
+2% +$953K
ALSN icon
16
Allison Transmission
ALSN
$9.47B
$57.7M 2.01%
1,387,500
+1,700
+0.1% +$69.9K
GILD icon
17
Gilead Sciences
GILD
$165B
$56.8M 1.98%
661,400
+9,600
+1% +$760K
WBS icon
18
Webster Financial
WBS
$12.3B
$55.7M 1.94%
1,176,761
-13,800
-1% -$691K
GD icon
19
General Dynamics
GD
$104B
$55.4M 1.93%
223,093
-1,700
-0.8% -$415K
IBOC icon
20
International Bancshares
IBOC
$4.77B
$53.1M 1.85%
1,160,306
-10,200
-0.9% -$491K
BERY
21
DELISTED
Berry Global Group, Inc.
BERY
$53M 1.85%
955,053
+11,543
+1% +$566K
ARW icon
22
Arrow Electronics
ARW
$10.5B
$52.9M 1.84%
505,903
+11,400
+2% +$1.18M
SAIC icon
23
Saic
SAIC
$4.95B
$52.5M 1.83%
473,100
-6,300
-1% -$664K
NOV icon
24
NOV
NOV
$6.86B
$52.5M 1.83%
2,511,342
-106,500
-4% -$2.23M
MKSI icon
25
MKS Inc
MKSI
$17.6B
$49.3M 1.72%
581,600
+570,900
+5,336% +$45.8M
1
2 3 4 5

Similar funds

HMH
Hackensack Meridian Health Edison, New Jersey $1.06B AUM 18.03% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return

Polaris Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Polaris Capital Management held 103 positions worth $2.87B, up 13% from $2.55B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Polaris Capital Management's Q4 2022 filing shows 3 new, 36 increased, 27 reduced and 7 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 596,900 shares worth $67.9M. The largest sale was Cinemark Holdings, an estimated $46.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Polaris Capital Management's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 596,900 shares worth $67.9M.
  • Polaris Capital Management added most to MKS Inc in Q4 2022, an estimated $45.8M increase.
  • Polaris Capital Management's biggest Q4 2022 reduction was Marathon Petroleum, cutting an estimated $40.4M.
  • Polaris Capital Management fully exited Cinemark Holdings in Q4 2022, selling an estimated $46.7M.
  • Polaris Capital Management's ten largest holdings make up 44% of its $2.87B portfolio in Q4 2022.
  • Polaris Capital Management opened 3 new positions and closed 7 in Q4 2022.
  • Polaris Capital Management's portfolio value rose 13% quarter-over-quarter to $2.87B.

Based on Polaris Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.